What is the role of ferumoxytol in endovascular aortic repair surveillance for patients with renal impairment?
Label:chem
Topic
Ferumoxytol is an ultrasmall superparamagnetic iron oxide particle that has minimal nephrotoxicity and is not associated with nephrogenic systemic fibrosis (NSF). It is FDA-approved for iron deficiency anemia and has been used off-label as a contrast agent for magnetic resonance imaging (MRI)/magnetic resonance angiography (MRA). This study explores its use in endovascular aortic repair (EVAR) surveillance for patients with renal impairment, particularly those with end-stage renal disease (ESRD).
From: "Ferumoxytol-enhanced magnetic resonance angiography for endovascular aortic repair surveillance in a patient after renal transplant", Journal of Vascular Surgery Cases, Innovations and Techniques, Volume 11, Issue 5, October 2025, 101898
Answer
Ferumoxytol serves as a safe and effective alternative contrast agent for MRI/MRA in patients with renal impairment undergoing EVAR surveillance. It enables high-quality imaging for detecting endoleaks without compromising renal function. In the case presented, ferumoxytol-enhanced MRA (Fe-MRA) successfully identified a type II endoleak that was not previously detected by computed tomography angiography (CTA). This highlights ferumoxytol's potential for improving diagnostic accuracy in EVAR surveillance for patients with compromised renal function.
Return to Home
Chemical List
Knowledge you may be interested in